肺癌EGFR第二代標靶藥物的日本研究(直向) Japanese Study on Second-Generation EGFR Targeted Therapy for Lung Cancer

深入探討來自日本的突破性研究，揭示第二代EGFR標靶藥物在肺癌治療中的功效。發現在對抗這種不屈不撓的疾病中的最新進展和潛在的改變者。
Delve into the groundbreaking research from Japan, unraveling the efficacy of second-generation EGFR targeted therapy in lung cancer treatment. Discover the latest advancements and potential game-changers in the fight against this relentless disease.
連結
https://pubmed.ncbi.nlm.nih.gov/37323187/